Cargando…
Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients
RATIONALE & OBJECTIVE: Cardiovascular disease is the major cause of mortality and morbidity in peritoneal dialysis (PD) patients. Adiponectin, a key adipokine, is related to obesity and insulin resistance. We determined the clinical and prognostic value of plasma adiponectin level and its adipos...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922972/ https://www.ncbi.nlm.nih.gov/pubmed/36793851 http://dx.doi.org/10.1016/j.xkme.2022.100589 |
_version_ | 1784887646506450944 |
---|---|
author | Than, Win Hlaing Chan, Gordon Chun-Kau Kwan, Bonnie Ching-Ha Lai, Ka-Bik Chan, Ronald Cheong-Kin Teoh, Jeromy Yuen Chun Ng, Jack Kit-Chung Fung, Winston Wing-Shing Chow, Kai-Ming Cheng, Phyllis Mei-Shan Law, Man-Ching Li, Philip Kam-Tao Szeto, Cheuk-Chun |
author_facet | Than, Win Hlaing Chan, Gordon Chun-Kau Kwan, Bonnie Ching-Ha Lai, Ka-Bik Chan, Ronald Cheong-Kin Teoh, Jeromy Yuen Chun Ng, Jack Kit-Chung Fung, Winston Wing-Shing Chow, Kai-Ming Cheng, Phyllis Mei-Shan Law, Man-Ching Li, Philip Kam-Tao Szeto, Cheuk-Chun |
author_sort | Than, Win Hlaing |
collection | PubMed |
description | RATIONALE & OBJECTIVE: Cardiovascular disease is the major cause of mortality and morbidity in peritoneal dialysis (PD) patients. Adiponectin, a key adipokine, is related to obesity and insulin resistance. We determined the clinical and prognostic value of plasma adiponectin level and its adipose tissue messenger RNA (mRNA) expression in new PD patients. STUDY DESIGN: Retrospective analysis of a prospective observational study. SETTING & PARTICIPANTS: 152 new PD patients from a single center; 6 adults undergoing abdominal surgeries without kidney disease served as controls. PREDICTORS: Plasma adiponectin level and its adipose tissue mRNA expression. OUTCOMES: Body build and composition, patient and technique survival. ANALYTICAL APPROACH: Adiponectin level and mRNA expression were grouped in quartiles for correlation analysis for body build and Cox regression for survival analysis. RESULTS: The median plasma adiponectin level was 31.98 μg/mL (IQR, 16.81-49.49 μg/mL), and adiponectin mRNA expression in adipose tissue was 1.65 times higher than in controls (IQR, 0.98-2.63). There was a modest but statistically significant correlation between plasma adiponectin and its adipose tissue mRNA expression (r = 0.40, P < 0.001). Plasma adiponectin level inversely correlated with body mass index, waist-hip ratio, mid-arm circumference, adipose tissue mass, plasma triglyceride (r = -0.39, -0.38, -0.41, -0.38, and -0.30, respectively; P < 0.001 for all), as well as serum insulin level (r = -0.24, P = 0.005). Similar correlations were present but less marked with adipose tissue adiponectin mRNA level. Neither plasma adiponectin level nor adipose tissue adiponectin mRNA level predicted patient or technique survival. LIMITATIONS: Observational study, single center, single baseline measurement. CONCLUSIONS: Plasma adiponectin level correlated with the degree of adiposity in new PD patients. However, neither plasma adiponectin level nor its adipose tissue mRNA expression was an independent prognostic indicator in kidney failure patients newly started on PD. |
format | Online Article Text |
id | pubmed-9922972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-99229722023-02-14 Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients Than, Win Hlaing Chan, Gordon Chun-Kau Kwan, Bonnie Ching-Ha Lai, Ka-Bik Chan, Ronald Cheong-Kin Teoh, Jeromy Yuen Chun Ng, Jack Kit-Chung Fung, Winston Wing-Shing Chow, Kai-Ming Cheng, Phyllis Mei-Shan Law, Man-Ching Li, Philip Kam-Tao Szeto, Cheuk-Chun Kidney Med Original Research RATIONALE & OBJECTIVE: Cardiovascular disease is the major cause of mortality and morbidity in peritoneal dialysis (PD) patients. Adiponectin, a key adipokine, is related to obesity and insulin resistance. We determined the clinical and prognostic value of plasma adiponectin level and its adipose tissue messenger RNA (mRNA) expression in new PD patients. STUDY DESIGN: Retrospective analysis of a prospective observational study. SETTING & PARTICIPANTS: 152 new PD patients from a single center; 6 adults undergoing abdominal surgeries without kidney disease served as controls. PREDICTORS: Plasma adiponectin level and its adipose tissue mRNA expression. OUTCOMES: Body build and composition, patient and technique survival. ANALYTICAL APPROACH: Adiponectin level and mRNA expression were grouped in quartiles for correlation analysis for body build and Cox regression for survival analysis. RESULTS: The median plasma adiponectin level was 31.98 μg/mL (IQR, 16.81-49.49 μg/mL), and adiponectin mRNA expression in adipose tissue was 1.65 times higher than in controls (IQR, 0.98-2.63). There was a modest but statistically significant correlation between plasma adiponectin and its adipose tissue mRNA expression (r = 0.40, P < 0.001). Plasma adiponectin level inversely correlated with body mass index, waist-hip ratio, mid-arm circumference, adipose tissue mass, plasma triglyceride (r = -0.39, -0.38, -0.41, -0.38, and -0.30, respectively; P < 0.001 for all), as well as serum insulin level (r = -0.24, P = 0.005). Similar correlations were present but less marked with adipose tissue adiponectin mRNA level. Neither plasma adiponectin level nor adipose tissue adiponectin mRNA level predicted patient or technique survival. LIMITATIONS: Observational study, single center, single baseline measurement. CONCLUSIONS: Plasma adiponectin level correlated with the degree of adiposity in new PD patients. However, neither plasma adiponectin level nor its adipose tissue mRNA expression was an independent prognostic indicator in kidney failure patients newly started on PD. Elsevier 2022-12-14 /pmc/articles/PMC9922972/ /pubmed/36793851 http://dx.doi.org/10.1016/j.xkme.2022.100589 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Than, Win Hlaing Chan, Gordon Chun-Kau Kwan, Bonnie Ching-Ha Lai, Ka-Bik Chan, Ronald Cheong-Kin Teoh, Jeromy Yuen Chun Ng, Jack Kit-Chung Fung, Winston Wing-Shing Chow, Kai-Ming Cheng, Phyllis Mei-Shan Law, Man-Ching Li, Philip Kam-Tao Szeto, Cheuk-Chun Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients |
title | Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients |
title_full | Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients |
title_fullStr | Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients |
title_full_unstemmed | Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients |
title_short | Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients |
title_sort | circulating and adipose tissue adiponectin level and outcomes in incident peritoneal dialysis patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922972/ https://www.ncbi.nlm.nih.gov/pubmed/36793851 http://dx.doi.org/10.1016/j.xkme.2022.100589 |
work_keys_str_mv | AT thanwinhlaing circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT changordonchunkau circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT kwanbonniechingha circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT laikabik circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT chanronaldcheongkin circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT teohjeromyyuenchun circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT ngjackkitchung circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT fungwinstonwingshing circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT chowkaiming circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT chengphyllismeishan circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT lawmanching circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT liphilipkamtao circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients AT szetocheukchun circulatingandadiposetissueadiponectinlevelandoutcomesinincidentperitonealdialysispatients |